Table-I.
Antibiotic sensitivity pattern of E. coli isolates
| Antibiotics | Codes | Disks |
Resistant
|
Intermediate
|
Sensitive
|
|||
|---|---|---|---|---|---|---|---|---|
|
R
|
I
|
S
|
||||||
| n | % | n | % | n | % | |||
| Cephradine (CR) | CR | 30 µg | 237 | 73.8 | 28 | 8.7 | 56 | 17.4 |
| Amikacin | AK | 30 µg | 41 | 12.7 | 56 | 17.4 | 224 | 71.7 |
| Streptomycin | S | 10 ug | 96 | 30 | 76 | 23.6 | 225 | 70 |
| Norfloxacin | NOR | 10 ug | 36 | 11.2 | 101 | 31.4 | 184 | 58.9 |
| Ciprofloxacin | CIP | 5 ug | 174 | 54.2 | 53 | 16.5 | 94 | 29.2 |
| Imipenem | IPM | 10 ug | 139 | 43.3 | 55 | 17.1 | 127 | 39.5 |
| Cefuroxime | CXM | 30 ug | 187 | 58.2 | 60 | 18.6 | 74 | 23.0 |
| Augmentin | AMC | 30 ug | 201 | 62.6 | 40 | 12.4 | 80 | 24.9 |
| Ceftriaxone | CRO | 30 ug | 139 | 43.3 | 60 | 18.6 | 122 | 38.0 |
| Gentamicin | CN | 10 ug | 192 | 59.8 | 44 | 13.7 | 85 | 26.4 |
| Aztreonam | ATM | 30 ug | 144 | 44.8 | 60 | 18.6 | 177 | 55.1 |
| Doxycycline | DO | 30 ug | 214 | 66.6 | 33 | 10.2 | 74 | 23 |
| Pipracillin-Tazobactam | TZP | 100/10 ug | 0 | 0 | 30 | 9.6 | 291 | 90.6 |
| Ceftazidime | CAZ | 30 ug | 237 | 73.8 | 32 | 9.9 | 52 | 16.1 |
| Tetracycline | TE | 30 ug | 223 | 69.4 | 29 | 9 | 69 | 21.4 |
| Cefaclor | CEC | 30 ug | 160 | 50 | 60 | 18.6 | 101 | 31.4 |
| Tazocin | TZP | 110/10 ug | 48 | 14.9 | 0 | 0 | 273 | 85 |
| Levofloxacin | LEV | 5 ug | 0 | 0 | 21 | 6.5 | 300 | 93.4 |
| Kanamycin | K | 30 ug | 64 | 19.9 | 100 | 31.1 | 157 | 48.9 |
| Meropenem | MEM | 10 ug | 0 | 0 | 0 | 0 | 321 | 100 |
| Amoxicillin | AMC | 20 ug | 321 | 100 | 0 | 0 | 0 | 0 |
| Pencillin | P | 10 u | 321 | 100 | 0 | 0 | 0 | 0 |
| Tobramycin | TOB | 10 ug | 0 | 0 | 0 | 0 | 321 | 100 |
| Cefotaxime | CTX | 30 ug | 288 | 89.7 | 0 | 0 | 33 | 10.2 |